Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A3571 LY2183240Summary: Blocker of anandamide uptake,highly potent
-
A4361 JNJ-1661010Summary: FAAH inhibitor,potent and selective
-
A4372 URB597Summary: FAAH inhibitor,potent and selective
-
A4374 PF-38451 CitationTarget: FAAHSummary: FAAH ihibitor,highly potent and selective
-
C4122 JNJ-42165279Summary: FAAH inhibitor
-
C4251 Oleoyl Ethyl AmideSummary: FAAH inhibitor with potential analgesic and anxiolytic activity
-
C4279 4-(n-nonyl) Benzeneboronic AcidSummary: FAAH and MAGL inhibitor
-
C4756 PF-622Summary: potent, time-dependent, irreversible FAAH inhibitor
-
C4983 JP83Summary: irreversible fatty acyl amide hydrolase (FAAH) inhibitor
-
C5178 Methyl α-Linolenyl FluorophosphonateSummary: inhibitor of phospholipases, FAAH